These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28852913)

  • 1. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.
    Bijlsma RM; Wessels H; Wouters RHP; May AM; Ausems MGEM; Voest EE; Bredenoord AL
    Fam Cancer; 2018 Apr; 17(2):309-316. PubMed ID: 28852913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing unsolicited findings in genomics: A qualitative interview study with cancer patients.
    Bijlsma RM; Wouters RHP; Wessels H; May AM; Ausems MGEM; Voest EE; Bredenoord AL
    Psychooncology; 2018 Apr; 27(4):1327-1333. PubMed ID: 29471587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.
    Meiser B; Storey B; Quinn V; Rahman B; Andrews L
    J Genet Couns; 2016 Apr; 25(2):218-27. PubMed ID: 26259529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.
    Rigter T; Henneman L; Kristoffersson U; Hall A; Yntema HG; Borry P; Tönnies H; Waisfisz Q; Elting MW; Dondorp WJ; Cornel MC
    Hum Mutat; 2013 Oct; 34(10):1322-8. PubMed ID: 23784691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered.
    Bijlsma RM; Bredenoord AL; Gadellaa-Hooijdonk CG; Lolkema MP; Sleijfer S; Voest EE; Ausems MG; Steeghs N
    Eur J Hum Genet; 2016 Oct; 24(10):1496-500. PubMed ID: 27071717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings.
    Roche MI; Griesemer I; Khan CM; Moore E; Lin FC; O'Daniel JM; Foreman AKM; Lee K; Powell BC; Berg JS; Evans JP; Henderson GE; Rini C
    Genet Med; 2019 May; 21(5):1092-1099. PubMed ID: 30237575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Am I My Family's Keeper? Disclosure Dilemmas in Next-Generation Sequencing.
    Wouters RH; Bijlsma RM; Ausems MG; van Delden JJ; Voest EE; Bredenoord AL
    Hum Mutat; 2016 Dec; 37(12):1257-1262. PubMed ID: 27647774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mainstreaming informed consent for genomic sequencing: A call for action.
    Bunnik EM; Dondorp WJ; Bredenoord AL; de Wert G; Cornel MC
    Eur J Cancer; 2021 May; 148():405-410. PubMed ID: 33784533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
    Marcus RK; Geurts JL; Grzybowski JA; Turaga KK; Clark Gamblin T; Strong KA; Johnston FM
    Fam Cancer; 2015 Dec; 14(4):641-9. PubMed ID: 26108897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients.
    Rigter T; van Aart CJ; Elting MW; Waisfisz Q; Cornel MC; Henneman L
    Clin Genet; 2014 May; 85(5):417-22. PubMed ID: 24117109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus document on the implementation of next generation sequencing in the genetic diagnosis of hereditary cancer.
    Soto JL; Blanco I; Díez O; García Planells J; Lorda I; Matthijs G; Robledo M; Souche E; Lázaro C
    Med Clin (Barc); 2018 Jul; 151(2):80.e1-80.e10. PubMed ID: 29439875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intention to learn results of genetic testing for hereditary colon cancer.
    Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of French populations towards the disclosure of unsolicited findings in medical genetics.
    Rosier M; Guedj M; Calvas P; Julia S; Garnier C; Cambon-Thomsen A; Muñoz Sastre MT
    J Health Psychol; 2021 Sep; 26(11):1767-1779. PubMed ID: 31707852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.
    Kaphingst KA; Ivanovich J; Lyons S; Biesecker B; Dresser R; Elrick A; Matsen C; Goodman M
    Transl Behav Med; 2018 Jan; 8(1):71-79. PubMed ID: 29385583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' Attitudes Towards Disclosure of Genetic Test Results to Family Members: The Impact of Patients' Sociodemographic Background and Counseling Experience.
    Gilbar R; Shalev S; Spiegel R; Pras E; Berkenstadt M; Sagi M; Ben-Yehuda A; Mor P; Perry S; Zaccai TF; Borochowitz Z; Barnoy S
    J Genet Couns; 2016 Apr; 25(2):314-24. PubMed ID: 26371363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
    Tafe LJ
    J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.
    Regier DA; Peacock SJ; Pataky R; van der Hoek K; Jarvik GP; Hoch J; Veenstra D
    CMAJ; 2015 Apr; 187(6):E190-E197. PubMed ID: 25754703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
    Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
    Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.